SymbolTEM
NameTEMPUS AI, INC.
SectorTECHNOLOGY
RegionNorth America
IndustryComputer Software: Programming, Data Processing
Address600 WEST CHICAGO AVENUE,SUITE 510, CHICAGO, Illinois, 60654, United States
Telephone+1 800 - 976-5448
Fax
Email
Websitehttps://www.tempus.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001717115
Description

Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we consider to be one of the largest libraries of clinical and molecular oncology data in the world. We have launched a suite of different products derived from our Platform, which have gained significant traction over the past five years. To date, our offerings have been used by approximately 95% of the largest public pharmaceutical companies.

Additional info from NASDAQ:
Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we consider to be one of the largest libraries of clinical and molecular oncology data in the world. We have launched a suite of different products derived from our Platform, which have gained significant traction over the past five years. To date, our offerings have been used by approximately 95% of the largest public pharmaceutical companies.

2026-08-19 21:03

📋 Eric Paul Lefkofsky (Officer) plans to sell 133K shares of TEMPUS AI, INC. (at $51.64 each, total $6.8M) Filed: Aug 19, 2026 | ID: 000029

Read more
2026-08-19 21:02

📋 Andrew Polovin (Officer) plans to sell 22K shares of TEMPUS AI, INC. (at $51.64 each, total $1.1M) Filed: Aug 19, 2026 | ID: 000016

Read more
2026-08-19 21:01

📋 Ryan Fukushima (Officer) plans to sell 41K shares of TEMPUS AI, INC. (at $51.64 each, total $2.1M) Filed: Aug 19, 2026 | ID: 000028

Read more
2026-08-19 20:59

📋 Ryan M. Bartolucci (Officer) plans to sell 6K shares of TEMPUS AI, INC. (at $51.64 each, total $319K) Filed: Aug 19, 2026 | ID: 000014

Read more
2026-08-19 20:58

📋 James William Rogers (Officer) plans to sell 23K shares of TEMPUS AI, INC. (at $51.64 each, total $1.2M) Filed: Aug 19, 2026 | ID: 000022

Read more
2026-08-19 20:56

📋 Thomas Edward Schoenherr (Officer) plans to sell 9K shares of TEMPUS AI, INC. (at $51.64 each, total $477K) Filed: Aug 19, 2026 | ID: 000012

Read more
2026-08-19 20:38

📋 JAMES ROGERS (Officer) plans to sell 26K shares of Tempus AI, Inc. (at $49.36 each, total $1.3M) Filed: Aug 19, 2026 | ID: 008428

Read more
2026-08-19 20:32

📋 ANDREW POLOVIN (Officer) plans to sell 8K shares of Tempus AI, Inc. (at $49.36 each, total $391K) Filed: Aug 19, 2026 | ID: 008418

Read more
2026-08-19 20:31

📋 THOMAS SCHOENHERR (Officer) plans to sell 8K shares of Tempus AI, Inc. (at $49.36 each, total $399K) Filed: Aug 19, 2026 | ID: 008417

Read more
2026-08-18 20:15

West Nadja 🔴 sold 3.0K shares of Tempus AI, Inc. (TEM) at $53.90 Transaction Date: Aug 14, 2026 | Filing ID: 000004

Read more